Artificial Intelligence — Artificial Intelligence in Children's Clinic
Citation(s)
Adamson AS, Welch HG Machine Learning and the Cancer-Diagnosis Problem - No Gold Standard. N Engl J Med. 2019 Dec 12;381(24):2285-2287. doi: 10.1056/NEJMp1907407.
Das N, Topalovic M, Janssens W Artificial intelligence in diagnosis of obstructive lung disease: current status and future potential. Curr Opin Pulm Med. 2018 Mar;24(2):117-123. doi: 10.1097/MCP.0000000000000459. Review.
Dilsizian SE, Siegel EL Artificial intelligence in medicine and cardiac imaging: harnessing big data and advanced computing to provide personalized medical diagnosis and treatment. Curr Cardiol Rep. 2014 Jan;16(1):441. doi: 10.1007/s11886-013-0441-8. Review.
Goldhahn J, Rampton V, Spinas GA Could artificial intelligence make doctors obsolete? BMJ. 2018 Nov 7;363:k4563. doi: 10.1136/bmj.k4563.
Hamet P, Tremblay J Artificial intelligence in medicine. Metabolism. 2017 Apr;69S:S36-S40. doi: 10.1016/j.metabol.2017.01.011. Epub 2017 Jan 11. Review.
Huang Q, Zhang F, Li X Machine Learning in Ultrasound Computer-Aided Diagnostic Systems: A Survey. Biomed Res Int. 2018 Mar 4;2018:5137904. doi: 10.1155/2018/5137904. eCollection 2018. Review.
Huang S, Yang J, Fong S, Zhao Q Artificial intelligence in cancer diagnosis and prognosis: Opportunities and challenges. Cancer Lett. 2020 Feb 28;471:61-71. doi: 10.1016/j.canlet.2019.12.007. Epub 2019 Dec 10. Review.
Kantarjian H, Yu PP Artificial Intelligence, Big Data, and Cancer. JAMA Oncol. 2015 Aug;1(5):573-4. doi: 10.1001/jamaoncol.2015.1203.
Kapoor R, Walters SP, Al-Aswad LA The current state of artificial intelligence in ophthalmology. Surv Ophthalmol. 2019 Mar - Apr;64(2):233-240. doi: 10.1016/j.survophthal.2018.09.002. Epub 2018 Sep 22. Review.
Keel S, Lee PY, Scheetz J, Li Z, Kotowicz MA, MacIsaac RJ, He M Feasibility and patient acceptability of a novel artificial intelligence-based screening model for diabetic retinopathy at endocrinology outpatient services: a pilot study. Sci Rep. 2018 Mar 12;8(1):4330. doi: 10.1038/s41598-018-22612-2.
Kreps GL, Neuhauser L Artificial intelligence and immediacy: designing health communication to personally engage consumers and providers. Patient Educ Couns. 2013 Aug;92(2):205-10. doi: 10.1016/j.pec.2013.04.014. Epub 2013 May 15.
Shen TL, Fu XL [Application and prospect of artificial intelligence in cancer diagnosis and treatment]. Zhonghua Zhong Liu Za Zhi. 2018 Dec 23;40(12):881-884. doi: 10.3760/cma.j.issn.0253-3766.2018.12.001. Chinese.
Wall J, Krummel T The digital surgeon: How big data, automation, and artificial intelligence will change surgical practice. J Pediatr Surg. 2020 Jan;55S:47-50. doi: 10.1016/j.jpedsurg.2019.09.008. Epub 2019 Nov 16. Review.
Wulsin DF, Gupta JR, Mani R, Blanco JA, Litt B Modeling electroencephalography waveforms with semi-supervised deep belief nets: fast classification and anomaly measurement. J Neural Eng. 2011 Jun;8(3):036015. doi: 10.1088/1741-2560/8/3/036015. Epub 2011 Apr 28.
Application of Artificial Intelligence in Children's Clinic
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
